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TO THE EDITOR
Many diseases are caused by single
amino-acid substitutions on key genes
because of the loss of stability, protein
misfolding, and changes in the inter-
action properties (Honig and Nicholls,
1995; Goldberg, 2003). Protein struc-
tures can be used to evaluate the
effect of missense mutations on disease-
associated proteins, especially on
highly polymorphic genes, where func-
tional studies are likely to be incom-
plete.
Considering the involvement of the
highly polymorphic melanocortin-1
receptor gene (MC1R) in melanoma pre-
disposition, we investigated the role of
the rare variants (minor allele frequency
o1%) found in this gene in the Spanish
population. A structural analysis was
performed by evaluating the amino-acid
substitutions in the context of a three-
dimensional (3D) model and comparing
their effects with available functional
data.
The MC1R gene, which is located on
chromosome 16q24.3 and codes for a
melanocyte-stimulating hormone recep-
tor with seven-transmembrane helices, is
to date the main genetic contributor to
sporadic melanoma predisposition
(Kennedy et al., 2001). It has already
been associated with melanoma in diffe-
rent Caucasian populations (Fernandez
et al., 2007; Ibarrola-Villava et al., 2010,
2012). It is highly polymorphic, with
more than 100 non-conservative
reported variants (Gerstenblith et al.,
2007). Most of these changes are
relatively rare, but their frequencies
vary among populations, and it appears
that they are more commonly found in
South European populations than in
those of North European descent
(Gerstenblith et al., 2007; Williams
et al., 2011).
Of the 1170 individuals sequenced
(710 non-related melanoma cases and
460 cancer-free controls), 697 (59.6%)
carried at least one MC1R variant, with
78 (11.2%) of them actually carrying a
rare variant. Overall, 6.7% (78 of 1170
individuals) of the Spanish population
carry a MC1R rare variant. We detec-
ted a total of 41 different MC1R variants.
Among these, 31 variants appear rarely
in Spain and variant Y298H appeared
for the first time in our population. We
have obtained statistically significant
individual associations with melanoma
for six variants: V60L, S83P, R151C,
I155T, R160W, and D294H (Supple-
mentary Table S1 online). The highest
ORs were estimated for I155T and
R160W (odds ratio (OR): 3.81; P-
value¼ 0.003 and OR: 3.83; P-
value¼ 0.001, respectively). The esti-
mated OR associated with carrying at
least one non-synonymous variant was
1.79 (P-value¼ 4.93 1011). How-
ever, the OR for carrying only one rare
variant was 0.97 (P-value¼0.93). There
are many common non-synonymous
MC1R variants associated with the red
hair color (RHC) phenotype: D84E,
R142H, R151C, I155T, R160W, and
D294H. The association of other com-
mon variants such as V60L, V92M, and
R163Q with the RHC phenotype has not
been clearly established, and therefore
these variants have been considered
non-red hair color (NRHC) (Wong and
Rees, 2005). Almost all carriers of rare
changes in the Spanish population tend
to have fair skin color. However, only
40% of them also harbored a RHC or
NRHC variant. Thus, rare variants might
slightly modulate skin pigmentation.
Different studies have demonstrated
the functional consequences of some of
these MC1R changes. Thus, mutations
in positions 84, 142, 151, 160, and
294 have been previously reported to
alter protein function (Ringholm et al.,
2004; Garcia-Borron et al., 2005;
Newton et al., 2007; Sanchez-Laorden
et al., 2009; Dessinioti et al., 2011).
In addition, previous functional studies
have validated some of the 3D model
prediction results. Position M128
appears to have no effect according to
in silico predictions; however, the 3D
model suggests it could be a putative
folding disrupter, later confirmed in a
functional study (Perez Oliva et al.,
2009).
Owing to the importance of MC1R
variants in pigmentation and melanoma
predisposition, we have undertaken a
comprehensive 3D structure modeling
of 29 non-synonymous changes detec-
ted in our population to further explain
putative implications of rare variants
(Table 1 and Figure 1). After evaluating
all changes according to MC1R struc-
ture, variant location and nature of the
amino-acid changes, 25 variants
seemed to have structural implications
and cluster in three different regions that
may explain their differences in func-
tionality: the GTPase/protein kinase C
(PKC) signaling region, an alleged a-
melanocyte-stimulating hormone (a-
MSH)-binding extracellular region, and
a novel central core protein region. The
first and better-known region harbors
some of the common RHC (R142H,
R151C, I155T, and R160W) and NRHC
(R163Q) variants. Although these var-
iants do not seem to bring about struc-
tural changes under the 3D model, they
are located in an intracellular region
thought to be a GTPase and PKC inter-
action area that initiates the receptor
downstream signaling pathway and
internalization of the receptor that con-
firms previously reported functionalityAccepted article preview online 11 November 2013; published online 12 December 2013
Abbreviations: 3D, three-dimensional; MC1R, melanocortin-1 receptor gene; MSH, melanocyte-
stimulating hormone; NRHC, non-red hair color; OR, odds ratio; PKC, protein kinase C; RHC, red hair
color
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(Garcia-Borron et al., 2005; Newton
et al., 2007; Dessinioti et al., 2011).
Interestingly, side chains of residues
I155, T157, R160, and R163 define a
common solvent-accessible area, a
PKC–binding domain comprising
157TLPR160 and 160RARR163 (Sanchez-
Laorden et al., 2009), and therefore,
variants in these positions could
explain impairment of PKC activity.
Rare variants R142C, R213W, and
T308M are located near this region.
Table 1. In silico analysis of MC1R variants
3D Model
Mutation SNPs3d Polyphen
Poly funct
data
Possible effects of
mutation Folding
Surface
exposed Region1 Predict
V60L (r) Benign F Conserved change No effect Yes Core
D84E (R) Effect F Conserved charge
larger residue
Effect No Core
V92M (r) Benign NF Conserved change No effect No —
R142H (R) Effect F Cytosolic conserved No effect No PKC/GTPase sig.
R151C (R) Effect F Cytosolic non-
conserved
No effect Yes PKC/GTPase sig.
I155T(R) Effect F Cytosolic non-
conserved
No effect Yes PKC/GTPase sig.
R160W (R) Effect F Cytosolic conserved No effect Yes PKC/GTPase sig.
R163Q (r) Benign F Cytosolic conserved No effect Yes PKC/GTPase sig.
D294H (R) Effect F Charge change Effect No Core
C35Y Effect F Non-conserved No effect Yes —
S41C Effect — Conserved change No effect No MSH binding
S41F Effect F Bulkier hydrophobic
change
Effect No MSH binding
F45L Effect — Conserved change No effect No —
S83P Effect — Induces distortion of
helix 2
Effect No Core
G89R Effect F Charged bulkier
residue
Effect Yes Core
V92L Benign — Conserved change No effect No Core
T95M Effect — Conserved change No effect No —
V122M Benign — Conserved change No effect Yes —
M128T Benign F Hydrophobic to small
polar
Effect No Core
R142C Effect — Non-conserved Effect No PKC/GTPase sig.
R213W Effect F Bulky hydrophobic
replacement
Effect Yes PKC/GTPase sig.
P268R Effect — Charged bulkier
residue
Effect Yes MSH binding
T272M Effect F Change to large
apolar
No effect Yes MSH binding
K278E Benign — Charge change No effect Yes MSH binding
N279K Effect — Non-conserved
change
No effect Yes MSH binding
N281S Effect NF Change to smaller
residue
No effect Yes MSH binding
A285V Benign — Bulkier residue No effect Yes MSH binding
Y298H Effect — Charge change Effect No Core
T308M Effect — Change to large
apolar
Effect Yes PKC/GTPase sig.
Abbreviations: 3D Model, three-dimensional model variant evaluation according to MC1R structure and variant location; F, functional data available; NF, non-
funtional data available; Predict, global evaluation of prediction model; Pub Funct data, previous published functional data on different MC1R variants; r, non-
red hair color variants; R, red hair color variants; —, non-described.
SNPs3d (http://www.snps3d.org/) and Polyphen (http://genetics.bwh.harvard.edu/pph2/) online tools.
, Probably damaging; , possibly damaging; , benign , predictive effect; , no predictive effect.
1Location in the three putative regions described by our group, PKC/GTPase sig., protein kinase C/GTPase signaling; —, estimated neutral variants that do not
correspond to any subregion of the protein.
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The second important region includes
the rest of the RHC (D84E and D294H)
and NRHC (V60L and V92M) variants,
plus other rare variants (S83P, G89R,
M128T, and Y298H). Variants located
in this central region may be involved in
protein folding processes, and therefore
may be important in the maintenance of
the receptor’s integrity.
Finally, we propose a third new func-
tional region that includes S41F, P268R,
T272M, K278E, N281S, and A285V rare
variants. All except S41F are located in
the extracellular end helical tips, and
although there is no evident structural
implication, we believe this domain
may be involved in a-MSH union
(Perez Oliva et al., 2009).
Rare variants located in positions 41,
128, 89, 213, and 308 are described to
alter protein function (Sanchez-Laorden
et al., 2007; Perez Oliva et al., 2009;
Ozola et al., 2013). M128T and R213W
showed marked loss of function and
displayed reduced cell surface expres-
sion and agonist binding affinity, while
variants S41F and G89R showed almost
complete loss of function with no detec-
table cell surface expression and complete
inability to activate the cAMP pathway.
Finally, residue T308 is described to be
implicated in protein phosphorylation.
Therefore, the ensuing outcomes of this
MC1R variant modeling are highly
consistent with data from previously
published functional MC1R studies.
To sum up, changes S41F, S83P,
G89R, R142C, M128T, R213W, P268R,
Y298H, and T308M (Figure 1b, high-
lighted in deep blue) are predicted to
have structural consequences, whereas
variants T272M, K278E, N279K, N281S,
and A285V (Figure 1b highlighted in
cyan) may have mild or no structural
implications, but may be potentially
important for protein recognition because
of their near extracellular location.
SNPs3d in silico predictions represent a
useful tool to evaluate amino-acid
change effects in a protein structure.
However, it can only discriminate
between damaging or benign effect.
Our model combines folding effects,
nature of the amino-acid substitution,
and location of both individual variants
and clusters. The use of 3D models may
constitute a robust and exploratory pre-
diction method, as it combines folding
and visualization of the amino-acid
changes, and therefore could be a pro-
mising tool to assess further functional
MC1R variant studies. To our knowledge,
this is the first time that a large number of
rare MC1R variants are evaluated by
taking into account the structural effects
of the resulting residue changes.
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Figure 1. MC1R three-dimensional model. Representation of 25 non-synonymous variants described in the Spanish population. (a) Location of red hair color
(RHC) and non-RHC (NRHC) variants. Positions: RHC are colored in red, whereas NRHC are colored in orange. (b) Location of potentially functional rare variants
according to MC1R structure. Positions: colored in deep blue and cyan. (c) Magnification of receptor’s core central region. (d) Detail of important residues in
protein kinase C (PKC) MC1R–binding domain. Residues are colored according to atom nature. Oxygen in red and nitrogen in purple.
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Somatic HRAS p.G12S Mutation Causes Woolly
Hair and Epidermal Nevi
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TO THE EDITOR
Woolly hair nevus (WHN) is a mosaic
disorder characterized by distinct pat-
terns of tightly curled scalp hair, which
can appear concurrently with epidermal
nevi (EN) at other sites (Peteiro et al.,
1989; Venugopal et al., 2012). Woolly
hair is also found in congenital disorders
resulting from mutations affecting diverse
cellular components, including
intermediate filament, adherens junction,
and signal–transduction proteins (Harel
and Christiano, 2012).
Embryonic somatic mutation causes
mosaic disorders, which appear in pat-
terns of ectodermal progenitor dorso-
vental migration. Somatic mutations
causing mosaic disorders, including
Proteus syndrome (Lindhurst et al.,
2011), port-wine stains (Shirley et al.,
2013), and EN (Levinsohn et al., 2013;
Sun et al., 2013), have been found using
exome sequencing.
Recognizing that exome sequencing
would permit identification of mutations
causing WHN, we ascertained two
cases. Our first (WHN100; Figure 1a–d)
case was a 10-year-old girl without
history of developmental delay who
had regions of slightly curly hair over
her occipital scalp from infancy, which
progressively curled with no scalp sur-
face change and lie alongside the areas
of straight hair. She had hyperpigmented
patches on her neck, trunk, and arms,
with more keratotic lesions on her
distal extremities, and acanthosis nigri-
cans in both axillae. There was linear
palmoplantar keratoderma (PPK) and
hyperkeratosis over most metacarpopha-
langeal and some proximal interphalan-
geal joints. Given concurrent PPK and
woolly hair, clinical concern for Naxos
or Carvajal syndromes led to regular
cardiology evaluations that found no
abnormalities.
Our second case (WHN101;
Figure 1e–h) was a 6-year-old girl whose
hair developed at age 1 and consisted of
a mixture of poker-straight hair and
curly, thin hair. In infancy, she devel-
oped linear dyspigmentation on the
right arm and trunk, which became
more raised and scaly on the distal
extremities over time. She had normal
development, with no cardiac or oph-
thalmic abnormalities found on routine
physical examination, cardiac mag-
netic resonance imaging, and serialAccepted article preview online 15 October 2013; published online 14 November 2013
Abbreviations: CS, Costello syndrome; KEN, keratinocytic epidermal nevus; LOH, loss of heterozygosity;
NS, nevus sebaceus; PPK, palmoplantar keratoderma; SNV, single nucleotide variation; WHN, woolly hair
nevus
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